HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,305-2,316 of 7,264
Drug study icon
CompletedNCT02918318

Fixed Doses of Intranasal Esketamine for treatment-resistant depression

Official study title

A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Subjects With Treatment Resistant Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Akita
DepressionMedication studyAges 20–64
Countries
Japan
Sponsor
Janssen Pharmaceutical K.K.
Behavioral study icon
CompletedNCT06275217

Mindful Yoga for Postpartum Depression

Official study title

The Effects of a Mindful Yoga Program on Mood Symptoms and Stress for Postpartum Women With Depressive Symptoms: a Randomized Controlled Clinical Trial

This study has finished and is no longer accepting participants.

In Hong Kong
DepressionBehavioural studyAges 18–60
Countries
China
Sponsor
The Hong Kong Polytechnic University
Drug study icon
CompletedNCT00844922

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous study (Study 28133/P05842)

Official study title

Double-blind, Placebo-controlled Trial Investigating the Safety of Re-exposure to 900 mg of Org 34517, Used as Adjunctive Therapy in Subjects With Psychotic Major Depression (Major Depressive Episode, Severe, With Psychotic Features), Who Participated in Trial 28130

This study has finished and is no longer accepting participants.

Location not clearly listed
Depression, SchizophreniaMedication studyAges 18–75
Countries
Sponsor
Merck Sharp & Dohme LLC
Device study icon
CompletedNCT05701345

Virtual Reality-based Medical Device for people with Depressive Disorder

Official study title

Prospective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Ilsan
DepressionDevice studyAges 19–64
Countries
South Korea
Sponsor
Omni C&S
Other study type icon
CompletedNCT05932407

A Database Survey of Comparison The Risk of Haemorrhage Between Vortioxetine Tablet Treatment and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment in people with Depression

Official study title

Post-marketing Database Survey: A Cohort Study of Comparison the Risk of Haemorrhage (Serious Intracranial Haemorrhage Such as Cerebral Haemorrhage and Subarachnoid Haemorrhage) Between Vortioxetine Tablets and SSRIs In Patients With Depression Using JMDC Claims Database

This study has finished and is no longer accepting participants.

In Tokyo
DepressionObservational study
Countries
Japan
Sponsor
Takeda
Drug study icon
CompletedACTRN12610000564055

Patterns of treatment resistance and switching strategies in unipolar affective disorder

Official study title

In patients with unipolar affective disorder who have failed to respond to an adequate trial of an antidepressant, is a switching strategy (from Citalopram to Despiramine or from Desipramine to Citalopram) more effective than a non-switching strategy in terms of response and remission rates?

This study has finished and is no longer accepting participants.

In Belgium
DepressionInterventional studyAges 18–90
Countries
Belgium
Sponsor
Group for the Study of Resistant Depression

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.